Citation Impact
Citing Papers
Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment
2010
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
2008
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer
2003
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Dissecting the metastatic cascade
2004
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes
1996
The perivascular niche regulates breast tumour dormancy
2013
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
1998
Cancer Metastasis: Building a Framework
2006 Standout
Tumor Cell Dissemination: Emerging Biological Insights from Animal Models and Cancer Patients
2013
Genetic instabilities in human cancers
1998 StandoutNature
Metastatic Stem Cells: Sources, Niches, and Vital Pathways
2014
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Early Metastasis of Human Solid Tumours: Expression of Cell Adhesion Molecules
2007
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Significance, detection and markers of disseminated breast cancer cells
2006
Environment-mediated drug resistance: a major contributor to minimal residual disease
2009
Detection and Clinical Importance of Micrometastatic Disease
1999
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
2015
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients
2003
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer micrometastases
2009
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Biological Characteristics of Micrometastatic Cancer Cells in Bone Marrow
1999
Parallel progression of primary tumours and metastases
2009
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Does tumour dormancy offer a therapeutic target?
2010
Clonal evolution in cancer
2012 StandoutNature
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours
1995
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Novel approaches to target the microenvironment of bone metastasis
2021
Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
2010
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients.
2001
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
2001 Standout
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors
2002
Metabolic reprogramming and cancer progression
2020 StandoutScience
In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.
1994
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
2001
Detection and characterization of carcinoma cells in the blood
1998
NK cell–mediated killing of target cells triggers robust antigen-specific T cell–mediated and humoral responses
2009 StandoutNobel
Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.
1999
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene
2000
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Works of D Kutter being referenced
Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
1993
Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
1991